I. INTRODUCTION
On July 6, 2005, the Centers for Medicare & Medicaid Services ("CMS") published an interim final rule to implement the competitive acquisition program ("CAP") for outpatient drugs and biologicals covered under Medicare Part B (the "CAP Rule"),1 as mandated by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 ("MMA").
By way of background, the MMA requires CMS to establish the CAP for the acquisition of and payment for competitively-biddable Part B covered drugs and biologicals effective January 1, 2006. Under the CAP, physicians will make an annual election to either: (1) obtain certain covered drugs and biologicals ("CAP drugs") from vendors selected through a competitive bidding process ("CAP vendors"), or (2) continue to directly purchase drugs and biologicals and be reimbursed under the average sales price ("ASP") system....
| This service is completely FREE but for the full article and thousands of other articles from 100+ countries please tell us about yourself by registering (and yes, our lawyers like to think you've read our Disclaimer). It only takes 30 seconds and as well as great content you get articles more relevant to you and other advanced features like an optional personalised once-weekly news alert and forward-to-colleague capabilities. We'll also remember your details so you don't have to login again - if you've registered before please login here or if you've forgotten your username click here and we'll remind you. We appreciate your time is important and will respect your privacy - THANK YOU for registering. |
Specific Questions relating to this article should be addressed directly to the author.
 | Do you have a question for the author? |
